Delivery Order SPE2DR25D1205-SPE2DR26F0WT0
- Not listed
- The Defense Logistics Agency awarded a $7,668.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,910.33 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count packaging) with an ultimate completion date of November 12, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $4,290.06 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,899.19 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a competitive procurement of pharmaceutical products supporting federal medical supply needs....
- The Defense Logistics Agency awarded a $5,928.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count units) on October 31, 2025, with a completion date of November 3, 2025. This competitively awarded, non-set-aside contract represents a small-value pharmaceutical procurement for military healthcare supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,746.44 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (90-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation on July 15, 2025, with an ultimate completion date of July 16, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $4,080.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count package). This firm fixed price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on October 27, 2025, with a ceiling value of $1,466.44 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply contract with DLA. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.35 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on September 17, 2025, with completion expected by September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Kerendia 10 mg tablets in a 30-count quantity, with a contract ceiling value of $10,409.41. This award represents a firm fixed-price, non-set-aside delivery order to be performed at the vendor's Conshohocken, Pennsylvania location, with an ultimate completion date of October 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WT0Delivery Order
The Defense Logistics Agency awarded a competitive delivery order valued at $1,603.18 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (90-count units), with an ultimate completion date of November 14, 2025. This non-set-aside contract represents a firm fixed price delivery order supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The contract vehicle supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key participant in the DLA's pharmaceutical distribution network for defense and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/13/25 |